[4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate

C34H33Cl2N9O5S — CID 89232934

IUPAC[4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate
SMILESCN(C)C(=O)Oc1ccc(C[C@H]2C(=O)N(Cc3cccc4sc(N)nc34)C[C@H]3N2C(=O)CN3N(CC#N)C(=O)NCc2ccc(Cl)c(Cl)c2)cc1
InChIInChI=1S/C34H33Cl2N9O5S/c1-41(2)34(49)50-23-9-6-20(7-10-23)15-26-31(47)42(17-22-4-3-5-27-30(22)40-32(38)51-27)18-28-44(19-29(46)45(26)28)43(13-12-37)33(48)39-16-21-8-11-24(35)25(36)14-21/h3-11,14,26,28H,13,15-19H2,1-2H3,(H2,38,40)(H,39,48)/t26-,28+/m0/s1
InChIKeyQUVOABNZQJLASV-XTEPFMGCSA-N
MW750.67 g/mol
LogP4.32
Rot. Bonds9

About [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate

[4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate (PubChem CID 89232934) has the molecular formula C34H33Cl2N9O5S and a molecular weight of 750.67 g/mol. Its IUPAC name is [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate.

Molecular Properties

Compound Name[4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate
PubChem CID89232934
Molecular FormulaC34H33Cl2N9O5S
Molecular Weight750.67 g/mol
Exact Mass749.17
IUPAC Name[4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate
SMILESCN(C)C(=O)Oc1ccc(C[C@H]2C(=O)N(Cc3cccc4sc(N)nc34)C[C@H]3N2C(=O)CN3N(CC#N)C(=O)NCc2ccc(Cl)c(Cl)c2)cc1
InChIInChI=1S/C34H33Cl2N9O5S/c1-41(2)34(49)50-23-9-6-20(7-10-23)15-26-31(47)42(17-22-4-3-5-27-30(22)40-32(38)51-27)18-28-44(19-29(46)45(26)28)43(13-12-37)33(48)39-16-21-8-11-24(35)25(36)14-21/h3-11,14,26,28H,13,15-19H2,1-2H3,(H2,38,40)(H,39,48)/t26-,28+/m0/s1
InChIKeyQUVOABNZQJLASV-XTEPFMGCSA-N
XLogP4.32
TPSA168.44 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds9
Heavy Atoms51
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500750.67
LogP ≤ 54.32
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'cyanamide', 'substructure': 'N/A'}

Analyze [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate?
The IUPAC name of [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate (CID 89232934) is [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate.
What is the SMILES notation for [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate?
The canonical SMILES for [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate is CN(C)C(=O)Oc1ccc(C[C@H]2C(=O)N(Cc3cccc4sc(N)nc34)C[C@H]3N2C(=O)CN3N(CC#N)C(=O)NCc2ccc(Cl)c(Cl)c2)cc1.
What is the InChIKey of [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate?
The InChIKey is QUVOABNZQJLASV-XTEPFMGCSA-N. The full InChI is InChI=1S/C34H33Cl2N9O5S/c1-41(2)34(49)50-23-9-6-20(7-10-23)15-26-31(47)42(17-22-4-3-5-27-30(22)40-32(38)51-27)18-28-44(19-29(46)45(26)28)43(13-12-37)33(48)39-16-21-8-11-24(35)25(36)14-21/h3-11,14,26,28H,13,15-19H2,1-2H3,(H2,38,40)(H,39,48)/t26-,28+/m0/s1.
What are the key properties of [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate?
[4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate has a molecular weight of 750.67 g/mol, XLogP of 4.32, 9 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[(5S,8aS)-7-[(2-amino-1,3-benzothiazol-4-yl)methyl]-1-[cyanomethyl-[(3,4-dichlorophenyl)methylcarbamoyl]amino]-3,6-dioxo-2,5,8,8a-tetrahydroimidazo[1,2-a]pyrazin-5-yl]methyl]phenyl] N,N-dimethylcarbamate is sourced from PubChem (CID 89232934), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).